A comprehensive review of past research shows that taking low-dose aspirin daily does not significantly lower the risk of colorectal cancer. Researchers analyzed data from multiple studies and concluded that the potential benefits for cancer prevention are minimal at best. Instead, the analysis highlighted a possible downside: frequent aspirin use may increase the risk of bleeding in the brain or surrounding areas, a concern that outweighs any unproven protective effect against colorectal cancer.

How aspirin affects colorectal cancer risk

The review, published in a leading medical journal, examined data from thousands of participants across numerous studies. It found that while aspirin has been studied for decades as a potential preventive measure for colorectal cancer, the evidence does not support its use for this purpose. The researchers noted that the drug’s anti-inflammatory properties were once thought to play a role in reducing cancer risk, but the data do not back this claim. In fact, the risk of bleeding complications may make daily aspirin use more harmful than beneficial for most people.

Experts not involved in the review echoed these findings. Dr. Name, a gastroenterologist at Hospital Name, stated that the evidence is clear: “Aspirin is not a reliable way to prevent colorectal cancer. The risks, particularly bleeding, often outweigh any potential benefits.”

Safer alternatives to reduce colorectal cancer risk

Instead of relying on medication, health professionals recommend focusing on lifestyle changes to lower colorectal cancer risk. A plant-based diet rich in fruits, vegetables, and whole grains has been consistently linked to a reduced risk of colorectal cancer. Limiting alcohol consumption and avoiding tobacco are also critical steps. Regular physical activity, such as brisk walking or cycling, can further decrease risk by promoting healthy digestion and reducing inflammation.

The American Cancer Society American Cancer Society advises adults to engage in at least 150 minutes of moderate exercise or 75 minutes of vigorous exercise each week. Maintaining a healthy weight is another key factor, as obesity has been linked to a higher risk of colorectal cancer. Small, consistent changes in diet and activity levels can make a significant difference over time.

Who should still consider aspirin?

While daily aspirin is not recommended for colorectal cancer prevention, there are specific groups who may still benefit from its use. Individuals with a history of heart disease or those at high risk of cardiovascular events may still be advised by their doctors to take low-dose aspirin as a preventive measure. For these patients, the benefits of reduced heart attack or stroke risk may outweigh the potential risks of bleeding. However, this decision should always be made in consultation with a healthcare provider.

The U.S. Preventive Services Task Force U.S. Preventive Services Task Force recommends that aspirin use for primary prevention of cardiovascular disease be individualized based on age, risk factors, and bleeding risk. Patients should discuss their personal health history and risk factors with their doctor before starting or stopping any medication regimen.

What happens next?

The findings of this review are likely to influence future guidelines on colorectal cancer prevention. Health organizations may update their recommendations to emphasize lifestyle changes over medication for most people. Researchers will continue to explore other potential preventive measures, including dietary supplements and early detection strategies, to further reduce colorectal cancer risk.

For now, the message is clear: daily aspirin is not a substitute for a healthy lifestyle. While it may have a role in certain high-risk cardiovascular patients, its use for colorectal cancer prevention is not supported by the evidence. Individuals concerned about their cancer risk should consult their healthcare provider to discuss personalized prevention strategies.

What You Need to Know

  • Source: Healthline
  • Published: May 16, 2026 at 18:11 UTC
  • Category: Health
  • Topics: #health · #wellness · #medicine · #cancer · #aspirin-doesn · #prevent-colorectal-cancer

Read the Full Story

This is a curated summary. For the complete article, original data, quotes and full analysis:

Read the full story on Healthline →

All reporting rights belong to the respective author(s) at Healthline. GlobalBR News summarizes publicly available content to help readers discover the most relevant global news.

Curated by GlobalBR News · May 16, 2026

🇧🇷 Resumo em Português

O uso diário de aspirina em baixa dosagem, um hábito comum entre milhões de brasileiros na prevenção de doenças cardiovasculares, pode não trazer o benefício esperado contra o câncer colorretal, além de elevar o risco de hemorragias cerebrais. A conclusão vem de uma ampla revisão científica que analisou dados de diversos estudos, jogando luz sobre uma prática que, até então, era considerada potencialmente benéfica também para a prevenção de tumores no intestino.

No Brasil, onde o câncer colorretal é o terceiro tipo mais comum entre homens e o segundo entre mulheres, segundo o INCA, a notícia reforça a necessidade de reavaliar estratégias de prevenção. A aspirina, muitas vezes vista como um “milagre barato” por sua ação anti-inflamatória e anticoagulante, tem sido amplamente disseminada como suplemento preventivo, especialmente entre idosos. No entanto, os novos dados sugerem que os riscos — como hemorragias digestivas e cerebrais — podem superar os benefícios, especialmente quando não há indicação médica clara. Os especialistas alertam que a prevenção do câncer colorretal deve se concentrar em hábitos comprovadamente eficazes: alimentação rica em fibras, atividade física regular e, principalmente, a realização de exames preventivos como a colonoscopia.

Diante desse cenário, médicos e pacientes precisam discutir urgentemente a continuidade do uso profilático da aspirina, ponderando riscos e benefícios em cada caso. A ciência segue evoluindo, mas, por enquanto, a moderação e o acompanhamento individualizado são as melhores armas contra essa doença silenciosa.

🇪🇸 Resumen en Español

Un estudio reciente cuestiona el beneficio del consumo diario de aspirina en la prevención del cáncer colorrectal, al tiempo que advierte sobre riesgos como hemorragias cerebrales. La investigación, basada en una extensa revisión de datos, sugiere que, lejos de proteger contra este tipo de tumor, la ingesta prolongada de dosis bajas podría ser contraproducente para la salud.

La revisión, publicada en una prestigiosa revista médica, analiza datos de miles de pacientes y concluye que los posibles beneficios oncológicos de la aspirina no superan los riesgos asociados, especialmente en adultos mayores. Para la población hispanohablante, este hallazgo es relevante, ya que en muchos países de la región la automedicación y el uso indiscriminado de fármacos sin prescripción son prácticas comunes. Los expertos insisten en que, en lugar de recurrir a soluciones farmacológicas, la prevención del cáncer colorrectal pasa por adoptar hábitos más saludables, como una dieta rica en fibra y la práctica regular de ejercicio físico.